Trials / Completed
CompletedNCT04611477
Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals
A Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy of Synbiotic 365 on Body Composition in Overweight and Obese Individuals.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- Vedic Lifesciences Pvt. Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Evaluate the effect of Synbiotic 365 (Version 5 and 7) on body composition in overweight and obese individuals as measured by change in body mass index (BMI) and the percentage of body fat from Day 0 to Day 84 when compared to placebo by Dual Energy X-ray Absorptiometry scan (DEXA) for body composition (Body Mass Index, Lean Body Mass, Body Fat, Fat Free Mass).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Rice Hulk | Placebo |
| OTHER | Synbiotic365 Ver 5 | Active Comparator |
| OTHER | Synbiotic365 Ver 7 | Active Comparator |
Timeline
- Start date
- 2020-09-28
- Primary completion
- 2021-10-29
- Completion
- 2021-10-29
- First posted
- 2020-11-02
- Last updated
- 2022-02-02
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT04611477. Inclusion in this directory is not an endorsement.